Alternative forms of hydration in patients with cancer in the last days of life: study protocol for a randomised controlled trial

Andrew Davies, Melanie Waghorn, Julia Boyle, Ann Gallagher, Sigurd Johnsen, Andrew Davies, Melanie Waghorn, Julia Boyle, Ann Gallagher, Sigurd Johnsen

Abstract

Background: The provision of clinically assisted hydration at the end of life is one of the most contentious issues in medicine, and indeed within the general population. The reasons for contention include: a) the lack of evidence for or against; b) the disparate opinions of healthcare professionals; and c) the generally positive opinions of patients and their carers about clinically assisted hydration.

Methods/design: The study is a cluster randomised trial to assess the feasibility of conducting an adequately powered, randomised controlled trial of clinically assisted hydration in patients with cancer in the last days of life. Twelve sites, four National Health Service (NHS) hospitals and eight NHS/voluntary sector hospices in the United Kingdom, will be randomised to give either standard intervention A: continuance of oral intake and regular mouth care, or standard intervention B: continuance of oral intake, regular mouth care and clinically assisted hydration. Patients will be included if they: i) have a diagnosis of cancer; ii) are aged ≥ 18 yr; iii) have an estimated prognosis of ≤ 1 week and iv) are unable to maintain sufficient oral intake (1 L per day, measured/estimated); and v) are able to give informed consent. Patients will be excluded if they have contra-indications to receiving clinically assisted hydration. The primary endpoint of interest is the frequency of hyperactive delirium ('terminal agitation'), and this will be assessed using the Modified Richmond Agitation and Sedation Scale (administered every four hours). Other data to be collected include the frequency of pain, respiratory secretions ('death rattle'), dyspnoea, nausea and vomiting, adverse effects to clinically assisted hydration and overall survival. In addition, data will be collected on the use of anti-psychotic drugs, sedative drugs, analgesics, anti-secretory drugs and other end-of-life medication. The study has obtained full ethical approval.

Discussion: A randomised controlled trial of clinically assisted hydration in end-of-life care is urgently required. This feasibility study will allow methodological and ethical issues to be understood and addressed to ensure that a robust, adequately powered, randomised controlled trial is designed.

Trial registration: ClinicalTrials.gov NCT02344927 (registered 4 June 2014).

References

    1. Craig GM. On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? J Med Ethics. 1994;20:139–43. doi: 10.1136/jme.20.3.139.
    1. Dunlop RJ, Ellershaw JE, Baines MJ, Sykes N, Saunders CM. On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? A reply. J Med Ethics. 1995;21:141–3. doi: 10.1136/jme.21.3.141.
    1. Allen E. Elderly patients are being ‘deprived of food and drink so they die quicker and free up bed space’, claim doctors. In Daily Mail: published 9 July 2012. .
    1. Whitehorn K. A thirst for palliative care: the Liverpool Care Pathway and withholding sustenance. In The Observer: published 30 December 2012. .
    1. Good P, Cavenagh J, Mather M, Ravenscroft P. Medically assisted hydration for adult palliative care patients. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD006273. DOI: 10.1002/14651858.CD006273.pub2.
    1. Parry R, Seymour J, Whittaker B, Bird L, Cox K. Rapid evidence review: pathways focused on the dying phase in end-of-life care and their key components. Published online July 2013. .
    1. del Rio MI, Shand B, Bonati P, Palma A, Maldonado A, Taboada P, et al. Hydration and nutrition at the end of life: a systematic review of emotional impact, perceptions, and decision-making among patients, family, and health care staff. Psycho-Oncology. 2012;21:913–21. doi: 10.1002/pon.2099.
    1. Raijmakers NJ, van Zuylen L, Costantini M, Caraceni A, Clark J, Lundquist G, et al. Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol. 2011;22:1478–86. doi: 10.1093/annonc/mdq620.
    1. Office for National Statistics. Deaths registered in England and Wales, 2012, .
    1. Neuberger J, Aaronovitch D, Bonset T, Charlesworth-Smith C, Cox D, Guthrie C, Hameed K, Harries R, Jackson R, Waller S. More care, less pathway. A review of the Liverpool Care Pathway. Published online July 2013. .
    1. Waller A, Hershkowitz M, Adunsky A. The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients. Am J Hosp Palliat Care. 1994;11:22–7. doi: 10.1177/104990919401100607.
    1. Viola RA. Studying fluid status and the dying. The challenge of clinical research. (MSc). University of Ottawa (Canada). Canada: University of Ottawa (Canada); 1997.
    1. Cerchietti L, Navigante A, Sauri A, Palazzo F. Hypodermoclysis for control of dehydration in terminal-stage cancer. Int J Palliat Nurs. 2000;6:370–4. doi: 10.12968/ijpn.2000.6.8.9060.
    1. Bruera E, Sala R, Rico MA, Moyano J, Centeno C, Willey J. Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. J Clin Oncol. 2005;23:2366–71. doi: 10.1200/JCO.2005.04.069.
    1. Morita T, Hyodo I, Yoshimi T, Ikenaga M, Tamura Y, Yoshizawa A, et al. Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol. 2005;16:640–7. doi: 10.1093/annonc/mdi121.
    1. Bruera E, Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, et al. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol. 2013;31:111–8. doi: 10.1200/JCO.2012.44.6518.
    1. Dev R, Dalal S, Bruera E. Is there a role for parenteral nutrition or hydration at the end of life? Curr Opin Support Palliat Care. 2012;6:365–70. doi: 10.1097/SPC.0b013e328356ab4a.
    1. Breitbart W, Chochinov HM, Passik SD. Psychiatric symptoms in palliative medicine. In: Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK, editors. p. 1453–82.
    1. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care. 1990;6:7–15.
    1. Breitbart W, Friedlander M. Confusion/delirium. In: Bruera E, Higginson IJ, Ripamonti C, von Gunten C, editors. Textbook of palliative medicine. London: Hodder Arnold; 2006. pp. 688–700.
    1. Leonard M, Agar M, Mason C, Lawlor P. Delirium issues in palliative care settings. J Psychosom Res. 2008;65:289–98. doi: 10.1016/j.jpsychores.2008.05.018.
    1. Sykes N, Thorns A. Sedative use in the last week of life and the implications for end-of-life decision making. Arch Intern Med. 2003;163:341–4. doi: 10.1001/archinte.163.3.341.
    1. Rinck GC, van den Bos GA, Kleijnen K, de Haes HJ, Schade E, Veenhof CH. Methodologic issues in effectiveness research on palliative care: a systematic review. J Clin Oncol. 1997;15:1697–707.
    1. Her Majesty’s Government. Mental Capacity Act 2005. .
    1. Dixon-Woods M, Angell EL. Research involving adults who lack capacity: how have research ethics committees interpreted the requirements? J Med Ethics. 2009;35:377–81. doi: 10.1136/jme.2008.027094.
    1. Farrand S, Campbell AJ. Safe, simple subcutaneous fluid administration. Br J Hosp Med. 1996;55:690–2.
    1. National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. 2013. .
    1. Rees E, Hardy J. Novel consent process for research in dying patients unable to give consent. Br Med J. 2003;327:19. doi: 10.1136/bmj.327.7408.198.
    1. Glasgow RE, McKay HG, Piette JD, Reynolds KD. The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns. 2001;44:119–27. doi: 10.1016/S0738-3991(00)00186-5.
    1. Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care patients. Am J Respir Crit Care Med. 2002;166:1338–44. doi: 10.1164/rccm.2107138.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere